| 1 | [SID22415356] | Active | Potency | 1.5849 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 2 | [SID22415356] | Active | Potency | 2.1192 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Hit Validation in Primary Screen [AID652023, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 2.1192 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Hit Validation in Primary Screen | | AID | 652023 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 3 | [SID22415356] | Active | Potency | 2.1192 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Hit Validation in Primary Screen [AID652023, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 2.1192 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): Hit Validation in Primary Screen | | AID | 652023 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 4 | [SID22415356] | Active | Potency | 3.6626 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 5 | [SID22415356] | Active | AC50 | 5.03 | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity [AID624133, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | AC50 | 5.03 [uM] | | BioAssay | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity | | AID | 624133 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID22415356] | Active | Potency | 5.6234 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 7 | [SID22415356] | Active | Potency | 7.0795 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 8 | [SID22415356] | Active | Potency | 7.0795 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 9 | [SID22415356] | Active | Potency | 7.0795 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 10 | [SID22415356] | Active | Potency | 7.0795 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 11 | [SID22415356] | Active | Potency | 8.1995 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 12 | [SID22415356] | Active | Potency | 8.9125 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 13 | [SID22415356] | Active | Potency | 9.2 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 14 | [SID22415356] | Active | Potency | 9.2 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 15 | [SID22415356] | Active | Potency | 9.2 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID22415356] | Active | Potency | 10 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 17 | [SID22415356] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID22415356] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID22415356] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID22415356] | Active | Potency | 16.3601 | qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling: Hit Validation in Primary Screen [AID651558, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling: Hit Validation in Primary Screen | | AID | 651558 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID22415356] | Active | Potency | 44.6684 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 22 | [SID22415356] | Active | Potency | 44.6684 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 23 | [SID22415356] | Active | Potency | 44.6684 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 24 | [SID22415356] | Active | Potency | 44.6684 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 25 | [SID22415356] | Active | AC50 | 45.74 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | AC50 | 45.74 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID22415356] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID22415356] | Active | | | Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput screening assay to identify activators of the GAA30 frataxin promoter [AID588350, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Counterscreen for activators of the GAA850 frataxin promoter: luminescence-based cell-based high throughput screening assay to identify activators of the GAA30 frataxin promoter | | AID | 588350 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID22415356] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the GAA850 frataxin (FXN) promoter [AID588351, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the GAA850 frataxin (FXN) promoter | | AID | 588351 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID22415356] | Active | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID22415356] | Active | | | HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules. [AID1381, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules. | | AID | 1381 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID22415356] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID22415356] | Active | | | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence [AID686952, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence | | AID | 686952 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID22415356] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 34 | [SID22415356] | Active | | | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation [AID1285, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation | | AID | 1285 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 35 | [SID22415356] | Active | | | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation [AID1285, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation | | AID | 1285 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 36 | [SID22415356] | Active | | | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation [AID1285, Type: screening] | amyloid precursor protein; APP [Homo sapiens] [gi:257380] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation | | AID | 1285 | | BioAssay type | screening | | Target | amyloid precursor protein; APP [Homo sapiens] [gi:257380] | | PubMed | | | Data Table |  |
|
| 37 | [SID22415356] | Active | | | uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex [AID588475, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588475 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 38 | [SID22415356] | Active | | | uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex [AID588475, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588475 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 39 | [SID22415356] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 40 | [SID22415356] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 41 | [SID22415356] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] | | PubMed | | | Data Table |  |
|
| 42 | [SID22415356] | Active | | | E3 Ligase HTS_1536 [AID1230, Type: screening] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | E3 Ligase HTS_1536 | | AID | 1230 | | BioAssay type | screening | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 43 | [SID22415356] | Active | | | E3 Ligase HTS_1536 [AID1230, Type: screening] | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | E3 Ligase HTS_1536 | | AID | 1230 | | BioAssay type | screening | | Target | E3 ubiquitin-protein ligase Mdm2 isoform MDM2 [Homo sapiens] [gi:89993689] | | PubMed | | | Data Table |  |
|
| 44 | [SID22415356] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 45 | [SID22415356] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 46 | [SID22415356] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 47 | [SID22415356] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 48 | [SID22415356] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 49 | [SID22415356] | Active | | | High throughput discovery of novel modulators of ROMK K+ channel activity: Retest of Primary Hits [AID1917, Type: other] | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | High throughput discovery of novel modulators of ROMK K+ channel activity: Retest of Primary Hits | | AID | 1917 | | BioAssay type | other | | Target | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] | | PubMed | | | Data Table |  |
|
| 50 | [SID22415356] | Active | | | High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen [AID1918, Type: screening] | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22415356 | | CID | 2176608 | | Outcome | Active | | BioAssay | High throughput discovery of novel modulators of ROMK K+ channel activity: Primary Screen | | AID | 1918 | | BioAssay type | screening | | Target | Potassium inwardly-rectifying channel, subfamily J, member 1 [Homo sapiens] [gi:223460826] | | PubMed | | | Data Table |  |
|